3ZQ0 Stock Overview

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. More details

3ZQ0 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€6M)

Earnings have declined by 46.8% per year over past 5 years

+ 1 more risk

Ayurcann Holdings Corp. Competitors

Biofrontera

XTRA:B8FK

€15.0m

SynBiotic

DUSE:SBX

€27.7m

Redx Pharma

DB:0RX

€65.0m

Cantourage Group

XTRA:HIGH

€59.9m

Price History & Performance

Summary of all time highs, changes and price drops for Ayurcann Holdings
Historical stock prices
Current Share Price	CA$0.013
52 Week High	CA$0.061
52 Week Low	CA$0.0065
Beta	1.45
11 Month Change	-33.33%
3 Month Change	-60.61%
1 Year Change	30.00%
33 Year Change	-88.18%
5 Year Change	n/a
Change since IPO	-89.78%

Recent updates

Shareholder Returns

	3ZQ0	DE Pharmaceuticals	DE Market
7D	-3.7%	1.2%	2.1%
1Y	30.0%	-11.6%	9.3%

Return vs Industry: 3ZQ0 exceeded the German Pharmaceuticals industry which returned -13% over the past year.

Return vs Market: 3ZQ0 exceeded the German Market which returned 9.7% over the past year.

Price Volatility

Is 3ZQ0's price volatile compared to industry and market?
3ZQ0 volatility
3ZQ0 Average Weekly Movement	35.4%
Pharmaceuticals Industry Average Movement	5.8%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.7%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: 3ZQ0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 3ZQ0's weekly volatility has decreased from 60% to 35% over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Igal Sudman	ayurcann.com

Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. It offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. The company sells product under the Fuego, H&S, and XPLOR brands.

Ayurcann Holdings Corp. Fundamentals Summary

How do Ayurcann Holdings's earnings and revenue compare to its market cap?
3ZQ0 fundamental statistics
Market cap	€3.91m
Earnings (TTM)	-€2.75m
Revenue (TTM)	€18.06m

0.2x

P/S Ratio

-1.4x

P/E Ratio

Is 3ZQ0 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3ZQ0 income statement (TTM)
Revenue	CA$26.99m
Cost of Revenue	CA$18.09m
Gross Profit	CA$8.91m
Other Expenses	CA$13.02m
Earnings	-CA$4.12m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.021
Gross Margin	33.00%
Net Profit Margin	-15.25%
Debt/Equity Ratio	244.9%

How did 3ZQ0 perform over the long term?

See historical performance and comparison

3ZQ0 Stock Overview

Risk Analysis

Ayurcann Holdings Corp. Competitors

XTRA:B8FK

€15.0m

DUSE:SBX

€27.7m

DB:0RX

€65.0m

XTRA:HIGH

€59.9m

Price History & Performance

Recent News & Updates

Ayurcann Holdings Corp. Announces Chief Financial Officer Changes, Effective December 2, 2024

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) cancelled the acquisition of Ayurcann Holdings Corp. (CNSX:AYUR).

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) cancelled the acquisition of Ayurcann Holdings Corp. (CNSX:AYUR).

Full year 2024 earnings released: CA$0.022 loss per share (vs CA$0.035 loss in FY 2023)

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) entered into a definitive business combination agreement to acquire Ayurcann Holdings Corp. (CNSX:AYUR).

Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.007 loss in 3Q 2023)

Recent updates

Ayurcann Holdings Corp. Announces Chief Financial Officer Changes, Effective December 2, 2024

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) cancelled the acquisition of Ayurcann Holdings Corp. (CNSX:AYUR).

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) cancelled the acquisition of Ayurcann Holdings Corp. (CNSX:AYUR).

Full year 2024 earnings released: CA$0.022 loss per share (vs CA$0.035 loss in FY 2023)

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) entered into a definitive business combination agreement to acquire Ayurcann Holdings Corp. (CNSX:AYUR).

Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.007 loss in 3Q 2023)

Second quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.001 loss in 2Q 2023)

Now 53% undervalued

Now 58% undervalued

First quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 1Q 2023)

Ayurcann Holdings Corp., Annual General Meeting, Dec 20, 2023

Full year 2023 earnings released: CA$0.035 loss per share (vs CA$0.026 loss in FY 2022)

Ayurcann Holdings Corp. Provides Corporate Update

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.005 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.001 profit in 1Q 2022)

High number of new and inexperienced directors

Ayurcann Holdings Corp., Annual General Meeting, Dec 21, 2022

Full year 2022 earnings released: CA$0.026 loss per share (vs CA$0.003 loss in FY 2021)

Ayurcann Holdings Corp. Expands Product Offerings Across Canada

Ayurcann Holdings Corp. (CNSX:AYUR) completed the acquisition of Joints and Hustle & Shake Inc. from Tetra Oils Inc. for CAD 3.6 million.

Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.011 loss in 3Q 2021)

High number of new and inexperienced directors

Ayurcann Holdings Corp. Receives Flower Sales Licence from Health Canada

Ayurcann Holdings Corp. (CNSX:AYUR) signed a letter of intent to acquire 100% interest in Joints and Hustle & Shake Inc. from Tetra Oils Inc.

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in FY 2020)

Shareholder Returns

Price Volatility

About the Company

Ayurcann Holdings Corp. Fundamentals Summary

0.2x

-1.4x

Earnings & Revenue